NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
Clinical trials for NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
500 chinese myeloma patients to be tracked on new immunotherapy regimens
Knowledge-focused Recruiting nowThis study will follow about 500 Chinese adults newly diagnosed with multiple myeloma who are starting immunotherapy as their first treatment. Researchers will collect data on which drug combinations are used and how well they work over one year, with longer follow-up for surviva…
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 04:31 UTC
-
New scan agent may spot myeloma earlier
Knowledge-focused Recruiting nowThis study tests whether a new radioactive tracer called 18F-fluciclovine can detect multiple myeloma better than the current standard tracer on PET/CT scans. About 60 adults with newly diagnosed or relapsed/refractory multiple myeloma will receive both tracers and have their sca…
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC